S737F was previously characterized in response to CFTR modulators in cultured nasal epithelial cells collected from five subjects, homozygous or heterozygous compound for this variant, with a variable diagnosis for CF disease, all subjects presenting pancreatic sufficiency [29]. This evidence concerns the gene CFTR and cystic fibrosis.